Tata 1mg
{{Short description|Healthcare platform in Gurugram, India}}
{{Use dmy dates|date=July 2022}}
{{Use Indian English|date=July 2022}}
{{Infobox company
| name = TATA 1mg
| logo = TATA 1mg Logo.svg
| logo_size = 250
| logo_caption =
| type = Private
| industry = {{plainlist|
| founded = {{Start date and age|2015}}
| founder = Prashant Tandon
Gaurav Agarwal
Vikas Chauhan
| hq_location_city = Gurugram, Haryana
| hq_location_country = India
| num_locations =
| area_served = India
| key_people = Prashant Tandon (CEO)
Gaurav Agarwal (CTO)
Vikas Chauhan
Tanmay Saksena (COO) {{Citation needed|reason=The information is available on the company about page, but the site is blacklisted by spam-filter|date=July 2021}}
| products = Medicine Supply
Healthcare Products
| services = {{plainlist|
| revenue = {{up}} {{INRConvert|1968|c}} (2024) {{Cite web|url=https://thearcweb.com/article/tata-1mgs-losses-narrow-75-revenue-rises-21-Kfp6LgYzrlJpaPxO|title=Tata 1mg FY24 results|date=27 August 2024 }}
| net_income = {{positive decrease}} {{INRConvert|-313|c}} (2024)
| revenue_year =
| num_employees = 800+ (2021){{cite web|title=1mg |url=https://www.owler.com/company/1mg |access-date=6 July 2021}}
| parent = Tata Digital
| subsid =
| website =
}}
Tata 1mg, previously 1mg,{{Cite news|date=2021-06-11|title=Tata Digital to acquire majority stake in 1MG|language=en-IN|work=The Hindu|url=https://www.thehindu.com/business/tata-digital-to-acquire-majority-stake-in-1mg/article34785024.ece|access-date=2021-08-16|issn=0971-751X}} is a healthcare platform based in Gurugram, India. It provides services, including e-pharmacy, diagnostics, e-consultation, and health content. It was founded in April 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan.{{Cite news|last=Narasimhan|first=T. E.|date=2019-03-01|title=Digital healthcare platform IMG Technologies to raise $70 million|work=Business Standard India|url=https://www.business-standard.com/article/companies/digital-healthcare-platform-img-technologies-to-raise-70-million-119030100197_1.html|access-date=2021-08-16}}{{Cite web|last=Sil|first=Debarghya|date=2020-11-04|title=Online Medical and Healthcare Platform 1mg Appoints Mayank Gupta as CFO|url=https://www.entrepreneur.com/article/359042|access-date=2021-08-16|website=Entrepreneur|language=en}}
History
In 2012, BLPL (Bright Lifecare Private Limited) started a digital health platform called HealthkartPlus.{{Cite news|last=Narasimhan|first=T. E.|date=2019-03-01|title=Digital healthcare platform IMG Technologies to raise $70 million|work=Business Standard India|url=https://www.business-standard.com/article/companies/digital-healthcare-platform-img-technologies-to-raise-70-million-119030100197_1.html|access-date=2021-07-26}} In 2015, Healthkart Plus separated from BLPL to form 1MG Technologies Private Limited.{{Cite web|last=Verma|first=Shrutika|date=2015-04-20|title=Healthkart gets $6 million for spun-off 1MG|url=https://www.livemint.com/Companies/Pi4fKcBNAN9nrMw1zHaODO/Healthkart-gets-6-million-for-spunoff-1MG.html|access-date=2021-07-26|website=mint|language=en}} Healthkart continued as a platform for fitness and health products; 1mg was a generic drug search business.{{Cite web|date=2015-04-20|title=Healthkart Separates & Rebrands HealthkartPlus To 1MG, Gets $6 Mn For The Newly Formed Entity|url=https://inc42.com/buzz/healthkart-separates-rebrands-healthkartplus-to-1mg-gets-6-mn-for-the-newly-formed-entity/|access-date=2021-08-16|website=Inc42 Media|language=en-US}} The Gurugram-based digital health startup maintains an online medicine database with information on side effects and generic substitutes and provides home delivery services for pharmacy, FMCG, and lab tests. In June 2021, Tata Digital Ltd. acquired a 55% stake in 1mg to form Tata 1mg.{{Cite web|title=E-health Startup 1mg Gets A $15 Million Booster Dose In Funding|url=https://www.forbesindia.com/article/special/ehealth-startup-1mg-gets-a-$15-million-booster-dose-in-funding/47681/1|access-date=2021-08-16|website=Forbes India|language=en}}
In 2023, Tata 1mg overtook PharmEasy as the market leader. PharmEasy's share dropped to 15% from roughly 33% during the same period, while Tata 1mg maintained a 31% market share, up from 19% in October 2022.{{Cite news |last=Web Team |first=BS |date=16 November 2023 |title=Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy market |work=Business Standard |url=https://www.business-standard.com/companies/news/tata-1mg-overtakes-pharmeasy-as-leaders-in-india-s-e-pharmacy-market-123111600366_1.html}}
In 2024, Tata 1mg and Vitonnix UK jointly introduced Vitamin Sublingual Sprays in Indian market. The first phase of the launch includes Vitamin D, Multivitamins, Biotin, and Melatonin.{{Cite web |last= |date=2024-01-10 |title=Tata 1mg & Vitonnix UK enter exclusive partnership in India |url=https://www.thestatesman.com/business/tata-1mg-vitonnix-uk-enter-exclusive-partnership-in-india-1503257795.html |access-date=2024-01-10 |website=The Statesman |language=en}}